Target intelligence / Profile preview

RNA, U6 small nuclear 1222, pseudogene (RNU6-1222P)

Target
RNU6-1222P
Molecular classification
Pseudogene, Non-coding RNA, Small nuclear RNA (snRNA)-derived pseudogene
01

Overview

RNU6-1222P is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA plays a critical role in the spliceosome, the molecular machine responsible for removing introns from pre-messenger RNA during RNA splicing[3][5]. However, RNU6-1222P itself does not code for a functional RNA and is not transcribed or translated into an active product. Pseudogenes like RNU6-1222P are believed to result from the retrotransposition of RNA intermediates and serve as evolutionary remnants in the genome[2]. There is no evidence that RNU6-1222P has any biological activity, disease association, or relevance as a therapeutic or diagnostic target[1][2]. If you are seeking information about the functional U6 snRNA gene or spliceosomal RNAs in general, the main entry should be "U6 small nuclear RNA," not RNU6-1222P[3].

Other names
RNU6-1222PRNA, U6 small nuclear 1222, pseudogene
02

Mechanism of action

None (As a non-functional pseudogene, there is no mechanistic action associated with therapeutics[1].)

03

Biological functions

None (RNU6-1222P itself is a non-functional pseudogene and does not participate in biological processes. The functional gene family, U6 snRNA, is involved in RNA splicing.)
04

Disease associations

None reported (No evidence that this specific pseudogene is associated with disease. U6 snRNA pseudogenes are generally considered genetic "fossils" with no active role in pathology[1][2].)
05

Safety considerations

None (There are no therapeutic or clinical implications for this pseudogene[1].)
06

Interacting drugs

None (No drugs are known to interact with this pseudogene[1].)
07

Biomarkers

None (RNU6-1222P is not used as a biomarker in clinical or research settings[1].)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1222, pseudogene (RNU6-1222P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1222, pseudogene (RNU6-1222P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call